Viewing nowCombinationTelmitri One Tablet 80/5/10 Milligrams (Telmisartan, Amlodipine, Rosuvastatin)
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.

MFDS item code 202500004 · Approved 2025.01.02 · Insurance code 655404780
Treatment of hypertension, improvement of dyslipidemia, and suppression of atherosclerosis progression and cardiovascular disease risk
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy and need to take rosuvastatin. The combination of telmisartan and amlodipine effectively lowers blood pressure and helps improve hypertension. Rosuvastatin primarily lowers serum cholesterol levels in patients with hypercholesterolemia and mixed dyslipidemia that cannot be managed solely by diet, thereby delaying the progression of atherosclerosis. It is also used as an adjunct in the treatment of familial hypercholesterolemia and dysbetalipoproteinemia. For patients at high risk of cardiovascular disease, a reduction in the risk of stroke, myocardial infarction, and arterial revascularization procedures can also be expected. Therefore, this medication is used to improve the condition of patients with both hypertension and dyslipidemia.
This medicine should be taken once daily as 1 tablet with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). This medicine is intended for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking telmisartan/amlodipine combination therapy together with rosuvastatin as a single agent, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose of each individual component (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older adults: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased up to a maximum of 20 mg once daily. 2. Older adults: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the rosuvastatin 40 mg dose is contraindicated in some of these patients. In a drug interaction study of the active ingredients in this medicine, telmisartan/amlodipine 80/10mg and rosuvastatin 20mg, in the presence of telmisartan/amlodipine, rosuvastatin Cmax increased by approximately 2.4-fold and AUC by approximately 1.3-fold. Therefore, when administering this medicine, the potential risk resulting from the increase in rosuvastatin Cmax should be evaluated, and patients should be monitored closely.
This medication can cause serious harm to the fetus or newborn if administered to pregnant women, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to any ingredients of this medication or similar drugs, those with certain hereditary diseases, significant liver or kidney dysfunction, or muscular diseases should not take it. Elderly patients, patients with very low blood pressure, patients with weakened liver or kidney function, and diabetic patients need special caution when taking this medication, and it should be taken carefully according to a physician's instructions. If symptoms such as muscle pain, weakness, or severe fatigue occur during the course of taking this medication, consult a physician immediately, and blood tests may be needed to check for muscle damage. This medication can affect liver function, so liver function tests should be performed regularly before and during treatment, and if liver enzyme levels significantly increase, the medication should be discontinued. Since interactions may occur when taken with other medications, if you are currently taking any other drugs, you must inform your doctor or pharmacist. During treatment with this medication, excessive alcohol consumption should be avoided, health status should be monitored regularly, and if any abnormal symptoms occur, consult healthcare professionals immediately. Women of childbearing potential should use appropriate contraception while taking this medication, and it is recommended that nursing mothers do not take this drug. The safety and efficacy of this medication have not been sufficiently confirmed in children, so it is advisable not to use it in that age group. In case of overdose, symptoms such as low blood pressure, dizziness, and arrhythmias may occur, so strict adherence to dosing is required, and if abnormal symptoms occur, you should visit a medical institution immediately.
This medication is sensitive to light, so it should be stored in a container that does not allow light in. Additionally, it is recommended to store the medication at room temperature, between 1 to 30 degrees Celsius, avoiding extremely hot or cold places.
Bright pink oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.